Integrating scRNA-seq and machine learning identifies MNAT1 as a therapeutic target in OSCC

Collectively, integrating T cell-Related Ubiquitination genes through advanced computational analyses, we established a robust prognostic model for OSCC and identified MNAT1 as a promoter of malignant progression, highlighting its therapeutic potential.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2025-10-29
DOI
https://doi.org/10.3389/fimmu.2025.1663487
Primary Topic
Single-cell and spatial transcriptomics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Integrating scRNA-seq and machine learning identifies MNAT1 as a therapeutic target in OSCC

Yu Shi, Weiping Yang, Jiayao Wang, L. Liu et al.
Frontiers in Immunology
Single-cell and spatial transcriptomics
article

Integrating scRNA-seq and machine learning identifies MNAT1 as a therapeutic target in OSCC

Yu Shi, Weiping Yang, Jiayao Wang, L. Liu, Han Gao, Qian Wang, Yanfei Wu
article en

Abstract

Collectively, integrating T cell-Related Ubiquitination genes through advanced computational analyses, we established a robust prognostic model for OSCC and identified MNAT1 as a promoter of malignant progression, highlighting its therapeutic potential.

Frontiers in ImmunologyVol. 16
Huzhou Normal University (CN), Third People's Hospital of Huzhou (CN)
Openalex Percentile: Top 72%
Single-cell and spatial transcriptomics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Integrating scRNA-seq and machine learning identifies MNAT1 as a therapeutic target in OSCC — Yu Shi, Weiping Yang, et al. · Frontiers in Immunology (2025) | TGRS Research Map | TGRS